# BRIMONIDINE TARTRATE
> **ANDA215225** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-03-29
## Drug
- **FDA Application Number:** ANDA215225
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BRIMONIDINE TARTRATE
- **Generic name:** BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%
- **Active ingredients:** BRIMONIDINE TARTRATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2023-03-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215225)
---
*AI Analytics · CC0 1.0*